Observational Feasibility Study of Home-based Training With Therabands in PAD-patients

KU Leuven20 enrolled

Overview

The study is an observational feasibility study to evaluate the feasibility of a combined aerobic+resistance training program in patients with IC.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Peripheral Artery Disease Intermittent Claudication

Interventions

aerobic+resistance exercise training programBEHAVIORAL

Personalized exercise program based on the inclusion testing and patient screening will be provided to the patient. The program will consist of a gradual walking program as well as a gradual resistance training program using therabands.

Eligibility

Sex: ALLMin age: 50 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age ≥ 50 yrs; * ankle-brachial index (ABI) ≤ 0.9 in one or two legs; * Fontaine stage II (Rutherford I 1-3) of PAD (new onset or conservatively treated); * body mass index \<35 kg/m 2 ; * resting systolic blood pressure (BP) \<160 mmHg and diastolic BP \<105 mmHg; * ability to walk at least 2 min at 2.0 mph; * ability to undertake an incremental treadmill test; * decrease of at least 15% in ABI after a maximal treadmill test; * not currently engaging in any regular exercise program. Exclusion Criteria: * exercise induced signs of myocardial ischemia or complex ventricular arrhythmias; * no access to laptop or internet; * no medical clearance for exercise

Locations (1)

KU Leuven

Leuven, Belgium

Outcomes

Primary Outcomes

user satisfaction

self-developed questionnaire based evaluation of user satisfaction

Time frame: 4 weeks

walking distance

pain free and maximal walking distance are recorded using the Gardner treadmill protocol.

Time frame: 4 weeks

Secondary Outcomes

Physical activity

Physical activity, defined total active energy expenditure (kcal) is obtained from objective measurement of physical activity during 7 consecutive days using the Sensewear device.

Time frame: 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.